#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrosarcoma metastatic Myotonic dystrophy Ornithine transcarbamoylase deficiency Endometrial cancer recurrent Sjogren's syndrome Becker's muscular dystrophy Cutaneous calcification PIK3CA related overgrowth spectrum Chronic granulomatous disease Arrhythmia Anaplastic thyroid cancer Mantle cell lymphoma recurrent Myxofibrosarcoma Neuroblastoma Nodal marginal zone B-cell lymphoma More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Diagnostics Factor IX deficiency – Life with Disease Mantle cell lymphoma – Treatment Rosai-Dorfman syndrome – Treatment Ornithine transcarbamoylase deficiency – Basic Information Loeys-Dietz syndrome – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Diagnostics Biotinidase deficiency – Life with Disease Chronic granulomatous disease Congenital hypotransferrinaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Arginine Hydrochloride Tamibarotene Terbinafine Siplizumab Alendronic Acid Tigulixostat Xxb750 Piromelatine Paracetamol Dc Methotrexate Hdp-101 Nido-361 LY3537021 Vibosameran DICLOFENAC POTASSIUM CLESROVIMAB Caffeine Citrate Obinutuzumab LINAPRAZAN GLURATE GSKVX000000039711 More therapies…

    Learn about Your Condition

    Psychotic behaviour Emphysema Tonsillitis Spinal osteoarthritis Patent ductus arteriosus Acute cardiac event Colorectal cancer metastatic Neurodegenerative disorder Erosive oesophagitis Alcohol use disorder Glucose tolerance impaired Mantle cell lymphoma stage III Tendon rupture Parkinson's disease Metabolic surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Pain Relief After Wisdom Tooth Surgery Using Etoricoxib and Celecoxib for Patients Undergoing Mandibular M3 Removal

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Etoricoxib
    • Celecoxib
    Hungary

  • Study on Choline Alfoscerate for Patients with Mild Cognitive Impairment

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • CHOLINE ALFOSCERATE
    Italy

  • Study on Methadone, Fentanyl, and Oxycodone for Reducing Pain After Heart Surgery in Adults

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Methadone Hydrochloride
    • Oxycodone Hydrochloride
    • Fentanyl Citrate
    Denmark

  • Study Comparing Secretin Synthetic Human and Endoscopic Aspiration Techniques for Analyzing Pancreatic Cancer in Patients with Intraductal Papillary Mucinous Neoplasia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Intraductal papillary mucinous neoplasm
    Investigated Drugs:
    • SECRETIN SYNTHETIC HUMAN
    Spain

  • Evaluation of tamsulosin and furosemide combination therapy after shock wave lithotripsy in patients with kidney stones

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrolithiasis
    Investigated Drugs:
    • Furosemide
    • Tamsulosin Hydrochloride
    • Ibuprofen
    Denmark

  • Study on the Safety and Effects of YTB323 and Drug Combination for Patients with Treatment-Resistant Generalized Myasthenia Gravis

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    • Human Normal Immunoglobulin (Iv)
    France
Previous Page
1 … 821 822 823 824 825 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!